<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39382415</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0971-5916</ISSN><JournalIssue CitedMedium="Internet"><Volume>159</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>The Indian journal of medical research</Title><ISOAbbreviation>Indian J Med Res</ISOAbbreviation></Journal><ArticleTitle>Exploratory analysis of serum Krebs von den Lungen-6, blood gas analysis &amp; Brixia score in determining COVID-19 severity &amp; mortality.</ArticleTitle><Pagination><StartPage>468</StartPage><EndPage>478</EndPage><MedlinePgn>468-478</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.25259/ijmr_2516_22</ELocationID><ELocationID EIdType="pii" ValidYN="Y">10.25259/ijmr_2516_22</ELocationID><Abstract><AbstractText>Background &amp; objectives Krebs von den Lungen-6 (KL-6) is primarily expressed by the damaged type II pneumocytes. In this context, the relationship of KL-6 with blood gas analysis (BGA) parameters and Brixia score is still limitedly discussed. This study aims to analyze the correlation of KL-6, BGA and Brixia scores to the severity and mortality of COVID-19. Methods A cross-sectional study was conducted in adult COVID-19 positive individuals at Universitas Airlangga Hospital, Surabaya, East Java, Indonesia, from March to August 2021. KL-6, BGA, and Brixia scores were compared according to severity (severe vs. non-severe) and mortality (non-survivor vs. survivor). The receiver operating characteristic (ROC) analysis was also performed to define the optimal cut-off, sensitivity, as well as the specificity of KL-6, BGA and Brixia scores to determine the COVID-19 severity and mortality. Results Total 35 severe and 20 non-severe COVID-19 positive individuals were enrolled in this study. Of those, there were 22 non-survivors. No significant difference in serum KL-6 levels was observed in the severity and mortality groups. KL-6 and HCO3- had positive correlation in the severe group (r=0.37). KL-6 and Brixia scores showed a significant negative correlation among COVID-19 positive individuals (r=-0.283; P=0.036). KL-6 and Brixia scores together served as the best severity markers in the current study [AUC 0.809 (0.697-0.920); Sn/Sp=0.686/0.900)], followed by KL-6 and P/F ratio [AUC 0.800 (0.637-0.963); Sn/Sp=0.971/0.750]. Interpretation &amp; conclusions The findings of this study suggest that KL-6 has the potential to be a useful adjunct laboratory parameter to the BGA and Brixia score representing COVID-19 severity and mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rosyid</LastName><ForeName>Alfian Nur</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Department of Pulmonology and Respiratory Medicine, Universitas Airlangga Hospital, Surabaya, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witarto</LastName><ForeName>Andro Pramana</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Universitas Airlangga Hospital, Surabaya, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witarto</LastName><ForeName>Bendix Samarta</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Universitas Airlangga Hospital, Surabaya, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Putra</LastName><ForeName>Achmad Januar Er</ForeName><Initials>AJE</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Universitas Airlangga Hospital, Surabaya, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pramudito</LastName><ForeName>Shidi Laras</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Universitas Airlangga Hospital, Surabaya, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soebakti</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Radiology, Universitas Airlangga Hospital, Surabaya, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sensusiati</LastName><ForeName>Anggraini Dwi</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Radiology, Universitas Airlangga Hospital, Surabaya, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nugraha</LastName><ForeName>Jusak</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Radiology, Universitas Airlangga Hospital, Surabaya, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amin</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pulmonology and Respiratory Medicine, Universitas Airlangga Hospital, Surabaya, Indonesia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Indian J Med Res</MedlineTA><NlmUniqueID>0374701</NlmUniqueID><ISSNLinking>0971-5916</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018396">Mucin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C060192">MUC1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018396" MajorTopicYN="Y">Mucin-1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007214" MajorTopicYN="N" Type="Geographic">Indonesia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001784" MajorTopicYN="Y">Blood Gas Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">KL-6</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2-severity</Keyword><Keyword MajorTopicYN="N">blood gas analysis</Keyword><Keyword MajorTopicYN="N">brixia</Keyword><Keyword MajorTopicYN="N">mortality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39382415</ArticleId><ArticleId IdType="pmc">PMC11463251</ArticleId><ArticleId IdType="doi">10.25259/ijmr_2516_22</ArticleId><ArticleId IdType="pii">10.25259/ijmr_2516_22</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Witarto AP, Witarto BS, Putra AJE, Pramudito SL, Rosyid AN. Serum Krebs von den Lungen-6 for predicting the severity of COVID-19 lung injury: A systematic review and meta-analysis. Iran Biomed J. 2021;25:381–9. doi: 10.52547/ibj.25.6.381.</Citation><ArticleIdList><ArticleId IdType="doi">10.52547/ibj.25.6.381</ArticleId><ArticleId IdType="pmc">PMC8744693</ArticleId><ArticleId IdType="pubmed">34641641</ArticleId></ArticleIdList></Reference><Reference><Citation>Susanto AD, Triyoga PA, Isbaniah F, Fairuz A, Cendikiawan H, Zaron F, et al. Lung fibrosis sequelae after recovery from COVID-19 infection. J Infect Dev Ctries. 2021;1:360–5. doi: 10.3855/jidc.13686.</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.13686</ArticleId><ArticleId IdType="pubmed">33839710</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Han Z, Heidari AA, Shou Y, Ye H, Wang L, et al. Detection of COVID-19 severity using blood gas analysis parameters and Harris hawks optimized extreme learning machine. Comput Biol Med. 2022;142:105166. doi: 10.1016/j.compbiomed.2021.105166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2021.105166</ArticleId><ArticleId IdType="pmc">PMC8701842</ArticleId><ArticleId IdType="pubmed">35077935</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotto R, Pinchera B, Perna F, Atripaldi L, Giaccone A, Sequino D, et al. Serum KL-6 could represent a reliable indicator of unfavourable outcome in patients with COVID-19 pneumonia. Int J Env Res Public. 2021;18:1–10. doi: 10.3390/ijerph18042078.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18042078</ArticleId><ArticleId IdType="pmc">PMC7924557</ArticleId><ArticleId IdType="pubmed">33672761</ArticleId></ArticleIdList></Reference><Reference><Citation>Suryananda TD, Yudhawati R. Association of serum KL-6 levels on COVID-19 severity: A cross-sectional study design with purposive sampling. Ann Med Surg. 2021;69:102673. doi: 10.1016/j.amsu.2021.102673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2021.102673</ArticleId><ArticleId IdType="pmc">PMC8359564</ArticleId><ArticleId IdType="pubmed">34401147</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue M, Zhang T, Chen H, Zeng Y, Lin R, Zhen Y, et al. Krebs Von den Lungen-6 as a predictive indicator for the risk of secondary pulmonary fibrosis and its reversibility in COVID-19 patients. Int J Biol Sci. 2021;17:1565–73. doi: 10.7150/ijbs.58825.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.58825</ArticleId><ArticleId IdType="pmc">PMC8071769</ArticleId><ArticleId IdType="pubmed">33907520</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezuidenhout MC, Wiese OJ, Moodley D, Maasdorp E, Davids MR, Koengelenberg CF, et al. Correlating arterial blood gas, acid-base and blood pressure abnormalities with outcomes in COVID-19 intensive care patients. Ann Clin Biochem. 2021;58:95–101. doi: 10.1177/0004563220972539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0004563220972539</ArticleId><ArticleId IdType="pubmed">33103442</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasher A. COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment. Postgr Med J. 2021;97:312–20. doi: 10.1136/postgradmedj-2020-138577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2020-138577</ArticleId><ArticleId IdType="pmc">PMC10017004</ArticleId><ArticleId IdType="pubmed">32978337</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghesi A, Maroldi R. COVID-19 outbreak in Italy: Experimental chest X-ray scoring system for quantifying and monitoring disease progression. Radiol Med. 2020;125:509–13. doi: 10.1007/s11547-020-01200-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11547-020-01200-3</ArticleId><ArticleId IdType="pmc">PMC7194501</ArticleId><ArticleId IdType="pubmed">32358689</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghesi A, Zigliani A, Masciullo R, Golemi S, Maculotti P, Farina D, et al. Radiographic severity index in COVID - 19 pneumonia : relationship to age and sex in 783 Italian patients. Radiol Med. 2020;125:461–4. doi: 10.1007/s11547-020-01202-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11547-020-01202-1</ArticleId><ArticleId IdType="pmc">PMC7194500</ArticleId><ArticleId IdType="pubmed">32358691</ArticleId></ArticleIdList></Reference><Reference><Citation>Poupin P, Bouleti C, Degand B, Paccalin M, Le Gal F, Bureau M-L, et al. Prognostic value of Charlson Comorbidity Index in the elderly with a cardioverter defibrillator implantation. Int J Cardiol Netherlands. 2020;314:64–9. doi: 10.1016/j.ijcard.2020.03.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2020.03.060</ArticleId><ArticleId IdType="pubmed">32291172</ArticleId></ArticleIdList></Reference><Reference><Citation>Signoroni A, Savardi M, Benini S, Adami N, Leonardi R, Gibellini P, et al. BS-Net: learning COVID-19 pneumonia severity on a large chest X-ray dataset Med Image Anal 2021;71102046.10.1016/j.media.2021.102046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.media.2021.102046</ArticleId><ArticleId IdType="pmc">PMC8010334</ArticleId><ArticleId IdType="pubmed">33862337</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman A, Munir SM, Yovi I, Makmur A. The relationship of chest X-ray in COVID-19 patients and disease severity in Arifin Achmad General Hospital Riau. J Respir. 2021;7:114–21. doi: 10.20473/jr.v7-i.3.2021.114-121.</Citation><ArticleIdList><ArticleId IdType="doi">10.20473/jr.v7-i.3.2021.114-121</ArticleId></ArticleIdList></Reference><Reference><Citation>Burhan E, Susanto AD, Isbaniah F, Nasution SA, Ginanjar E, Pitoyo CW, et al., editors. Pedoman Tatalaksana COVID-19. 3rd ed. Jakarta: PDPI, PERKI, PAPDI, PERDATIN, IDAI; 2020. pp. 1–138.</Citation></Reference><Reference><Citation>Azur MJ, Stuart EA, Frangakis C, Leaf PJ. Multiple imputation by chained equations: what is it and how does it work? Int J Methods Psychiatr Res. 2011;20:40–9. doi: 10.1002/mpr.329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mpr.329</ArticleId><ArticleId IdType="pmc">PMC3074241</ArticleId><ArticleId IdType="pubmed">21499542</ArticleId></ArticleIdList></Reference><Reference><Citation>Madley-Dowd P, Hughes R, Tilling K, Heron J. The proportion of missing data should not be used to guide decisions on multiple imputation. J Clin Epidemiol. 2019;110:63–73. doi: 10.1016/j.jclinepi.2019.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2019.02.016</ArticleId><ArticleId IdType="pmc">PMC6547017</ArticleId><ArticleId IdType="pubmed">30878639</ArticleId></ArticleIdList></Reference><Reference><Citation>Awano N, Inomata M, Kuse N, Tone M, Takada K, Muto Y, et al. Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019. Respir Investig. 2020;58:440–7. doi: 10.1016/j.resinv.2020.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resinv.2020.07.004</ArticleId><ArticleId IdType="pmc">PMC7441928</ArticleId><ArticleId IdType="pubmed">32863199</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue M, Zheng P, Bian X, Huang Z, Huang H, Zeng Y, et al. Exploration and correlation analysis of changes in Krebs von den Lungen-6 levels in COVID-19 patients with different types in China. Biosci Trends. 2020;14:290–6. doi: 10.5582/bst.2020.03197.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/bst.2020.03197</ArticleId><ArticleId IdType="pubmed">32565512</ArticleId></ArticleIdList></Reference><Reference><Citation>Horimasu Y, Hattori N, Ishikawa N, Kawase S, Tanaka S, Yoshioka K, et al. Different MUC1 gene polymorphisms in German and Japanese ethnicities affect serum KL-6 levels. Respir Med. 2012;106:1756–64. doi: 10.1016/j.rmed.2012.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2012.09.001</ArticleId><ArticleId IdType="pubmed">22995277</ArticleId></ArticleIdList></Reference><Reference><Citation>Remuzgo-Martínez S, Atienza-Mateo B, Ocejo-Vinyals JG, Genre F, Pulito-Cueto V, Mora-Cuesta VM, et al. Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome. Nature. 2021;11:22574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8604941</ArticleId><ArticleId IdType="pubmed">34799647</ArticleId></ArticleIdList></Reference><Reference><Citation>Djalante R, Lassa J, Setiamarga D, Sudjatma A, Indrawan M, Haryanto B, et al. Review and analysis of current responses to COVID-19 in Indonesia: Period of January to March 2020. Prog Disaster Sci. 2020;6:100091. doi: 10.1016/j.pdisas.2020.100091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pdisas.2020.100091</ArticleId><ArticleId IdType="pmc">PMC7149002</ArticleId><ArticleId IdType="pubmed">34171011</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon B, Tiwari M, Gopi A, Raj P, Panwar K. Serum krebs von den lungen-6 (KL-6): a promising biomarker in sarcoidosis. MOJ Curr Res Rev. 2018;1:44–7. doi: 10.15406/mojcrr.2018.01.00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.15406/mojcrr.2018.01.00009</ArticleId></ArticleIdList></Reference><Reference><Citation>Sada K, Yamamoto R, Yano A, Miyauchi A, Kawamura M, Ito H. Bicarbonate concentration as a predictor of prognosis in moderately severe COVID-19 patients: A multicenter retrospective study. PLoS One. 2022;17:e0270141. doi: 10.1371/journal.pone.0270141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0270141</ArticleId><ArticleId IdType="pmc">PMC9232226</ArticleId><ArticleId IdType="pubmed">35749694</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng D-H, Luo Y, Huang L-J, Liao F-L, Liu Y-Y, Tang P, et al. Correlation of Krebs von den Lungen-6 and fibronectin with pulmonary fibrosis in coronavirus disease 2019 Clin Chim Acta 2021517:48–53.10.1016/j.cca.2021.02.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2021.02.012</ArticleId><ArticleId IdType="pmc">PMC7898973</ArticleId><ArticleId IdType="pubmed">33631198</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergantini L, Bargagli E, D, ’, Alessandro M, Refini RM, Cameli P, Galasso L, et al. Prognostic bioindicators in severe COVID-19 patients. Cytokine. 2021;141:155455. doi: 10.1016/j.cyto.2021.155455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2021.155455</ArticleId><ArticleId IdType="pmc">PMC7843114</ArticleId><ArticleId IdType="pubmed">33548798</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Y, Wang D, Chen C, Lu W, Liu H, Lv T, et al. PaO2/FiO2 and IL-6 are risk factors of mortality for intensive care COVID - 19 patients. Sci Rep. 2021;11:7334. doi: 10.1038/s41598-021-86676-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-86676-3</ArticleId><ArticleId IdType="pmc">PMC8016870</ArticleId><ArticleId IdType="pubmed">33795768</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinatti G, Santini SJ, Tarantino G, Picchi G, Cosimini B, Ranfone F, et al. PaO2/FiO2 ratio forecasts COVID-19 patients’ outcome regardless of age: a cross-sectional, monocentric study. Intern Emerg Med. 2022;17:665–73. doi: 10.1007/s11739-021-02840-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-021-02840-7</ArticleId><ArticleId IdType="pmc">PMC8505469</ArticleId><ArticleId IdType="pubmed">34637082</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatti M, Calandri M, Biondo A, Geninatti C, Piatti C, Ruggirello I, et al. Emergency room comprehensive assessment of demographic, radiological laboratory and clinical data of patients with COVID-19: Determination of its prognostic value for in-hospital mortality. Intern Emerg Med. 2022;17:205–14. doi: 10.1007/s11739-021-02669-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-021-02669-0</ArticleId><ArticleId IdType="pmc">PMC7938271</ArticleId><ArticleId IdType="pubmed">33683539</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>